Addition of eicosapentaenoic acid to maintenance anti-depressant therapy in diabetes patients with major depressive disorder: a double-blind, placebo-controlled pilot study

Category Primary study
Registry of TrialsISRCTN registry
Year 2006
Addition of eicosapentaenoic acid (1 g/day) to maintenance anti-depressant therapy in diabetes patients with major depression will be associated with a reduction of depression symptoms, compared to placebo (1 g grapeseed oils).
Epistemonikos ID: 9eff9146489e142af45768b99cd28bb21adb0747
First added on: Jan 20, 2016